Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 2832-2834, July 15, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malkinson, A. M.
Right arrow Articles by Festing, M. F. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malkinson, A. M.
Right arrow Articles by Festing, M. F. W.

Butylated Hydroxytoluene Exposure Is Necessary to Induce Lung Tumors in BALB Mice Treated with 3-Methylcholanthrene1

Alvin M. Malkinson2, Kelli M. Koski, W. Alun Evans and Michael F. W. Festing

Department of Pharmaceutical Sciences, School of Pharmacy, Colorado Cancer Center, University of Colorado Health Sciences Center, Denver, Colorado 80262 [A. M. M., K. M. K.], and Medical Research Council Toxicology Unit, University of Leicester, Leicester, United Kingdom [W. A. E., M. F. W. F.]

Chronic butylated hydroxytoluene (BHT) treatment after a single administration of a carcinogen increases lung tumor multiplicity in some inbred strains of mice. We report that BALB/cOla and BALB/cByJ mice given a low dose (10 µg/g of body weight) of 3-methylcholanthrene (MCA) develop no lung tumors unless this is followed by chronic BHT exposure. Slightly higher MCA doses (15 and 25 µg/g) induce low lung tumor multiplicities (0.6 and 1.9 tumors/mouse, respectively) that are increased 12–26-fold by chronic BHT administration. This low-dose MCA/BHT model in BALB mice will facilitate the identification of genes regulating susceptibility to lung tumor promotion and pulmonary chemopreventative agents that act at a postinitiation site.

1 Supported by USPHS Grant CA33497 and by Grant 9510 from the American Institute for Cancer Research.

2 To whom requests for reprints should be addressed, at Department of Pharmaceutical Sciences, School of Pharmacy. Colorado Cancer Center, University of Colorado Health Sciences Center, 4200 East 9th Street, Denver, CO 80262. Phone: (303) 315-4579; Fax: (303) 315-6281; E-mail: al.malkinson@uchsc.edu.

Received 4/ 7/97. Accepted 6/ 2/97.




This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
A. K. Bauer, D. Dixon, L. M. DeGraff, H.-Y. Cho, C. R. Walker, A. M. Malkinson, and S. R. Kleeberger
Toll-Like Receptor 4 in Butylated Hydroxytoluene-Induced Mouse Pulmonary Inflammation and Tumorigenesis
J Natl Cancer Inst, December 7, 2005; 97(23): 1778 - 1781.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. A. Blaine, A. M. Meyer, G. Hurteau, M. Wick, J. A. Hankin, R. C. Murphy, A. J. Dannenberg, M. W. Geraci, K. Subbaramaiah, and R. A. Nemenoff
Targeted over-expression of mPGES-1 and elevated PGE2 production is not sufficient for lung tumorigenesis in mice
Carcinogenesis, January 1, 2005; 26(1): 209 - 217.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. A. Whitsett, C. J. Bachurski, K. C. Barnes, P. A. Bunn Jr., L. M. Case, D. N. Cook, D. Crooks, M. W. Duncan, L. Dwyer-Nield, R. C. Elston, et al.
Functional Genomics of Lung Disease
Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2/S1): S1 - S81.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
L. R. Kisley, B. S. Barrett, L. D. Dwyer-Nield, A. K. Bauer, D. C. Thompson, and A. M. Malkinson
Celecoxib reduces pulmonary inflammation but not lung tumorigenesis in mice
Carcinogenesis, October 1, 2002; 23(10): 1653 - 1660.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. M. Malkinson, R. A. Radcliffe, and A. K. Bauer
Quantitative trait locus mapping of susceptibilities to butylated hydroxytoluene-induced lung tumor promotion and pulmonary inflammation in CXB mice
Carcinogenesis, March 1, 2002; 23(3): 411 - 417.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. L. Keith, Y. E. Miller, Y. Hoshikawa, M. D. Moore, T. L. Gesell, B. Gao, A. M. Malkinson, H. A. Golpon, R. A. Nemenoff, and M. W. Geraci
Manipulation of Pulmonary Prostacyclin Synthase Expression Prevents Murine Lung Cancer
Cancer Res., February 1, 2002; 62(3): 734 - 740.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. M. Gressani, S. Leone-Kabler, M.G. O'Sullivan, L.D. Case, A. M. Malkinson, and M. S. Miller
Strain-dependent lung tumor formation in mice transplacentally exposed to 3-methylcholanthrene and post-natally exposed to butylated hydroxytoluene
Carcinogenesis, November 1, 1999; 20(11): 2159 - 2165.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. M. Brown, A. M. Malkinson, D. E. Rannels, and S. R. Rannels
Compensatory Lung Growth after Partial Pneumonectomy Enhances Lung Tumorigenesis Induced by 3-Methylcholanthrene
Cancer Res., October 1, 1999; 59(20): 5089 - 5092.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.